Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 2/20 | 0.41 |
| ▸ | LTA4H | P09960 | 1/20 | 0.39 |
| ▸ | LAP3 | P28838 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3750881 | 0.93 | MME (0.41) | MMELTA4HLAP3 | |
| SCHEMBL3750892 | 0.93 | MME (0.41) | MMELTA4HLAP3 | |
| Threonine SCHEMBL28512021 | 0.93 | MME (0.38) | MMELTA4H | |
| SCHEMBL29374335 | 0.91 | ACE (0.36) | MME | |
| SCHEMBL21828612 | 0.91 | ACE (0.36) | MME | |
| SCHEMBL29757021 | 0.90 | MME (0.42) | MMELTA4HLAP3 | |
| SCHEMBL34470345 | 0.90 | MME (0.42) | MMELTA4HLAP3 | |
| SCHEMBL7163147 | 0.90 | BACE1 (0.42) | — | |
| SCHEMBL7163139 | 0.90 | BACE1 (0.42) | — | |
| SCHEMBL30658572 | 0.89 | ERAP2 (0.40) | MME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230393140-A1 | BINDING ASSAYS INVOLVING A PLURALITY OF SYNTHETIC COMPOUNDS, TARGETS, AND COUNTER TARGETS | SRI INTERNATIONAL (US) | 2023-12-07 | — | — | US | disclosed |
| EP-4229211-A1 | BINDING ASSAYS INVOLVING A PLURALITY OF SYNTHETIC COMPOUNDS, TARGETS, AND COUNTER TARGETS | SRI International (US) | 2023-08-23 | — | — | EP | disclosed |
| WO-2022082006-A1 | BINDING ASSAYS INVOLVING A PLURALITY OF SYNTHETIC COMPOUNDS, TARGETS, AND COUNTER TARGETS | SRI INTERNATIONAL (US) | 2022-04-21 | — | — | WO | disclosed |